As the US braces for the what's the follow after the end of the Title 43 pandemic-related restrictions, experts discuss the ramifications with Cheddar News.

Share:
More In Politics
DEA’s No. 2 Quits Amid Reports of Previous Consulting Work for Big Pharma
The U.S. Drug Enforcement Administration’s second-in-command has quietly stepped down amid reporting by The Associated Press that he once consulted for a pharmaceutical distributor sanctioned for a deluge of suspicious painkiller shipments and did similar work for the drugmaker that became the face of the opioid epidemic: Purdue Pharma.
Load More